Ekso Bionics Holdings, Inc.
NCM: EKSOLive Quote
📈 ZcoreAI Score
Our AI model analyzes Ekso Bionics Holdings, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get EKSO Z-Score →About Ekso Bionics Holdings, Inc.
Healthcare
Medical Instruments & Supplies
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
📊 Fundamental Analysis
Ekso Bionics Holdings, Inc. demonstrates a profit margin of -91.4%, which is below the sector average, suggesting competitive pressure.
The company recently reported -38.3% revenue growth, which is negative, indicating a recent decline in revenue.
Return on Equity (ROE) is -107.6%, which indicates that capital utilization is currently under pressure.
At a current price of $9.02, EKSO currently sits at the 58th percentile of its 52-week range (Range: $2.73 - $13.50).
🏥 Financial Health
🔴
Profit Margin
Weak
⚠️
Debt/Equity
Moderate
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$32.14M
Trailing P/E
--
Forward P/E
-47.47
Beta (5Y)
0.78
52W High
$13.50
52W Low
$2.73
Avg Volume
133K
Day High
Day Low